Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response

Background: Differently from HIV-1, HIV-2 disease progression usually takes decades without antiretroviral therapy and the majority of HIV-2 infected individuals survive as elite controllers with normal CD4+ T cell counts and low or undetectable plasma viral load. Neutralizing antibodies (Nabs) are...

ver descrição completa

Detalhes bibliográficos
Autor principal: Rocha, Cheila (author)
Outros Autores: Calado, Rita (author), Borrego, Pedro (author), Marcelino, José M. (author), Bártolo, Inês (author), Rosado, Lino (author), Cavaco-Silva, Patrícia (author), Gomes, Perpétua (author), Família, Carlos (author), Quintas, Alexandre (author), Skar, Helena (author), Leitner, Thomas (author), Barroso, Helena (author), Taveira, Nuno (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Texto completo:https://doi.org/10.1186/1742-4690-10-110
País:Portugal
Oai:oai:run.unl.pt:10362/30200